SLC7A11 and cancer: SLC7A11 promotes the synthesis of GSH, counteracts the oxidative stress state in cells, and inhibits ferroptosis in cancer cells. SLC7A11 was overexpressed or up-regulated in patients suffered from NSCLC32, and silencing of SLC7A11 increased the curative effect of cisplatin to cancer cells33.